The Vasoview Hemopro 2 Endoscopic Vessel Harvesting System (Model VH-4000; UDI 00607567700406) i...

FDA Device Recall #Z-2741-2026 - Class II, June 2, 2026

Recall Summary

Recall Number Z-2741-2026
Classification Class II - Moderate risk
Date Initiated June 2, 2026
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Maquet Cardiovascular, LLC
Location Wayne, NJ
Product Type Devices
Quantity 205 units

Product Description

The Vasoview Hemopro 2 Endoscopic Vessel Harvesting System (Model VH-4000; UDI 00607567700406) is a sterile, single-use Class II device that was cleared for marketing by FDA under 510(k) number K101274.

Reason for Recall

Getinge identified that Vasoview Hemopro 2 devices from Lot 3000547797 were exposed to an out-of-specification sterilization dose during a gamma sterilization run (Run ID 1183-28782A) performed by STERIS at its Whippany, NJ facility between March 31 and April 1 of 2026.

Distribution Pattern

US Nationwide distribution in the states of NY, CA, SC, FL, TX, GA, OR.

Lot / Code Information

UDI 00607567700406, Serial/Lot Number 3000547797

Other Recalls from Maquet Cardiovascular, LLC

Recall # Classification Product Date
Z-2586-2025 Class II Heartstring III Proximal Seal System. Intravas... Aug 15, 2025
Z-2588-2025 Class II Heartstring III Proximal Seal System, 4.3 MM. I... Aug 15, 2025
Z-2587-2025 Class II Heartstring III Proximal Seal System, 3.8 MM. I... Aug 15, 2025
Z-2636-2025 Class II Vasoview Hemopro 3 Endoscopic Vessel Harvesting... Aug 6, 2025
Z-1622-2025 Class II The VASOVIEW HEMOPRO 2 Endoscopic Vessel Harves... Mar 20, 2025

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately, you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.